Stada Arzneimittel

ots Ad hoc-Service: STADA Arzneimittel AG STADA Arzneimittel AG exceeds sales and earnings targets in the 1st half of 2000

The sender is solely responsible for the contents of this announcement. -----------------------------------------------------

    Bad Vilbel (ots Ad hoc-Service) -        

    STADA Arzneimittel AG, based in Bad Vilbel near Frankfurt, today published its half-year results. The company which is listed on the SMAX has managed to increase sales and earnings stronger than planned.

    In the first half-year, STADA achieved consolidated sales of DM 461.9 million, an increase of +39% over the same period in 1999. Excluding acquisitions, sales grew by +29%. Once again, numerous national and international subsidiaries recorded growth rates well in excess of the respective markets. Thanks to the significantly better than expected growth in sales, STADA has been able to raise its annual target for consolidated sales, to around DM 870 million (growth of +25% compared to the previous year), and expects to cross the DM 1 billion sales mark in 2001.

    Consolidated earnings also far exceeded targets. Earnings before interest, tax, depreciation and amortisation (EBITDA) grew to DM 49.7 million in the 1st half-year and half-year net income rose to DM 19.2 million. Before deduction of extraordinary expenses of DM 6.9 million incurred in connection with the capital measures in the 2nd quarter (more than DM 270 million in funds obtained from the capital increase and warrant issue), the EBITDA figure is as high as DM 56.5 million (+42% compared to the same period in previous year) and, taking into account the German tax rate, the half-year net income figure rises to DM 23.0 million (+48% compared to the same period in the previous year). The income tax ratio within the group, which fell from 45% to 38%, played its part in the outstanding growth in net income for the year. STADA is certain of being able to increase EBITDA by a comfortable, double-digit percentage margin in the current fiscal year.

    Further information on STADA Arzneimittel AG, and the complete half- year report 2000, can be found on the internet at

    End of message ----------------------------------------------------- Internet:

Original-Content von: Stada Arzneimittel, übermittelt durch news aktuell

Weitere Meldungen: Stada Arzneimittel

Das könnte Sie auch interessieren: